DOAC‐Stop in lupus anticoagulant testing: Direct oral anticoagulant interference removed in most samples

BACKGROUND: The use of direct oral anticoagulants (DOACs) is a convenient therapeutic option for patients at risk of thrombosis. DOACs interfere with clot‐based testing for the identification of lupus anticoagulant antibodies (LACs) in patients with antiphospholipid syndrome (APS), a common cause of...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Steven Andrew, Jin, Jing, Pfaffroth, Christopher, Vu, Trang, Zehnder, James L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles ‐ Thrombosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938630/
https://www.ncbi.nlm.nih.gov/pubmed/33733031
http://dx.doi.org/10.1002/rth2.12472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938630/
https://www.ncbi.nlm.nih.gov/pubmed/33733031
http://dx.doi.org/10.1002/rth2.12472

Ejemplares similares